Categorie -wet- en regelgeving

bv CGR, GDPR

wet- en regelgeving

EMA’s safety committee recommends restriction on use of Lemtrada for multiple sclerosis patients

3 weken geleden

Pharma Biz

wet- en regelgeving

EMA validates Vertex’s MAA for elexacaftor, tezacaftor & ivacaftor triple combination treatment in CF

3 weken geleden

Pharma Biz

wet- en regelgeving

EMA’s PRAC committee recommends Xeljanz to be used with caution for all patients at high risk of blood clots

3 weken geleden

Pharma Biz

wet- en regelgeving

Astellas' Xospata gets European approval as monotherapy for patients with relapsed/refractory AML with FLT3 mutation

4 weken geleden

Pharma Biz

wet- en regelgeving

Eerste vaccin ter bescherming tegen ebola

1 maand geleden

apothekersnieuws.nl

wet- en regelgeving

2019 saw the FDA approve more generic drugs than ever before

1 maand geleden

InPharm.com

Advertentie(s)

Copyright 2019 © Uitgave van Medix Publishers BV | Privacy disclaimer